Tradestie Institutional Equity Comparison Engine

TPST vs FEMY โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

FEMY Overall Edge

FEMY Captures Institutional Edge (2โ€“1 Pillars ยท 4โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Femasys Inc. Common Stock (FEMY) driven by superior Momentum & Technical, Options & Structure while TPST counters with relative strength in Growth & Margin. Fundamentally, TPST trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus FEMY at N/M Forward P/E and -763.9% operating margin (-18.9% YoY). In options structure, TPST sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro) against FEMY sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
TPST N/M vs FEMY N/M Fwd P/E
Growth & Margin Winner TPST
Op Margin 0.0% vs -763.9% ยท YoY +0.0% vs -18.9%
Momentum & Technical Winner FEMY
1Y -96.1% vs +54.8% ยท 52W Pos 0% vs 17%
Options & Structure Winner FEMY
BREAKDOWN (N/A IV) vs UNCLASSIFIED (N/A IV)
TPST NASDAQ
Tempest Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$0.34
-10.5% 1D
Market Cap $7.6M
1M Return -45.24%
1Y Return -96.14%
Forward P/E N/M
Unified AI Score
39.3 / 100 SELL
Tech 25.0 Fund 52.0 Flow 50.0 Mom 55.0
FEMY NASDAQ
Femasys Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$1.28
-9.86% 1D
Market Cap $11.9M
1M Return -22.42%
1Y Return +54.78%
Forward P/E N/M
Unified AI Score
52.6 / 100 HOLD
Tech 61.0 Fund 62.0 Flow 50.0 Mom 64.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: TPST -96.14% FEMY +54.78% Spread: +150.92 pp (FEMY Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period TPST Revenue FEMY Revenue TPST Op. Margin FEMY Op. Margin Margin Edge
FY2016 $0M N/A -12406.1% N/A TPST
FY2017 $0M N/A -28585.1% N/A TPST
FY2020 N/A $0M N/A -668.0% FEMY
FY2021 N/A $0M N/A -706.7% FEMY
FY2022 N/A $0M N/A -961.7% FEMY
FY2023 N/A $0M N/A -1353.4% FEMY
FY2024 N/A $0M N/A -1091.8% FEMY
FY2025 N/A $0M N/A -767.0% FEMY

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: TPST (2) vs FEMY (4)
Institutional Metric TPST FEMY Criterion Row Winner
Market Capitalization Scale $7.6M $11.9M Larger Scale Tie
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% -18.9% Higher Growth TPST
Operating Margin (TTM) Profitability 0.0% -763.9% Higher Margin TPST
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -1797.6% -425.0% Higher ROE FEMY
52-Week Range Position Momentum 0% ($0โ€“$10) 17% ($0โ€“$6) Stronger Trend FEMY
Beta / 30D Volatility Risk Regime 0.75ฮฒ ยท 89% Vol 4.01ฮฒ ยท 72% Vol Lower Realized Risk FEMY
Unified Institutional Score Composite Signal 39.3 / 100 (SELL) 52.6 / 100 (HOLD) Higher Composite FEMY

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full TPST vs FEMY Buy Guide
TPST BREAKDOWN
40d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live TPST Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
FEMY UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live FEMY Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither TPST nor FEMY registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.